{"id":"placebo-pills","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo)"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo Pills","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:43:06.238129+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T05:43:22.112320+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:43:13.175502+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo Pills","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:43:13.913671+00:00"}},"_dailymed":null,"aiSummary":"Placebo Pills, marketed by NYU Langone Health, currently holds a unique position in the pharmaceutical market without a defined primary indication or direct competitors. The key composition patent is set to expire in 2028, which may provide a period of market exclusivity and revenue protection. However, the lack of a clear mechanism and primary indication poses a significant risk, potentially limiting its market appeal and adoption.","mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo effects operate through psychological and neurobiological pathways, including expectation, conditioning, and activation of the brain's reward and pain-modulation systems. While placebos contain no active pharmaceutical ingredient, they can produce measurable clinical improvements in subjective symptoms such as pain, nausea, and fatigue, particularly in conditions with strong psychosomatic components. Placebo pills are used clinically and in research as control comparators and, in some cases, as therapeutic tools when the placebo effect itself is the intended mechanism.","oneSentence":"Placebo pills produce therapeutic effects through the patient's expectation and belief that they will work, activating endogenous healing mechanisms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:18.399Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T05:43:22.112376+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Control comparator in clinical trials"},{"name":"Symptomatic relief in conditions with significant placebo-responsive components (e.g., chronic pain, irritable bowel syndrome)"}]},"trialDetails":[{"nctId":"NCT04050410","phase":"EARLY_PHASE1","title":"Autonomic Determinants of POTS - Pilot1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2019-08-27","conditions":"Postural Tachycardia Syndrome","enrollment":48},{"nctId":"NCT06029296","phase":"EARLY_PHASE1","title":"Diclofenac as a KMO Inhibitor","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2024-07-31","conditions":"Alcohol Use Disorder","enrollment":12},{"nctId":"NCT04140721","phase":"EARLY_PHASE1","title":"Autonomic Determinants of POTS - Pilot 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-08-31","conditions":"Postural Tachycardia Syndrome","enrollment":48},{"nctId":"NCT06063486","phase":"PHASE2","title":"Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2024-03-01","conditions":"Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome","enrollment":30},{"nctId":"NCT04599478","phase":"PHASE2, PHASE3","title":"Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2021-06-29","conditions":"Loss-of-control Eating, Obesity/Overweight","enrollment":160},{"nctId":"NCT05538910","phase":"NA","title":"Defining Neurobiological Links Between Substance Use and Mental Illness","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-02-02","conditions":"Major Depressive Disorder, Substance Use Disorder, Normal Physiology","enrollment":620},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT06610968","phase":"NA","title":"Acute Vitamin D Supplementation on Testosterone in Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2025-07-01","conditions":"Female Hormone Profile","enrollment":20},{"nctId":"NCT03941808","phase":"NA","title":"Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2019-06-17","conditions":"Vitiligo","enrollment":50},{"nctId":"NCT03804229","phase":"PHASE3","title":"Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Capital Medical University","startDate":"2019-10-29","conditions":"Vascular Dementia","enrollment":707},{"nctId":"NCT05815602","phase":"PHASE3","title":"Ebastine Versus Mebeverine in IBS Patients","status":"RECRUITING","sponsor":"Guy Boeckxstaens","startDate":"2023-03-30","conditions":"IBS - Irritable Bowel Syndrome, IBS","enrollment":200},{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT03668041","phase":"PHASE3","title":"National Adaptive Trial for PTSD Related Insomnia","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-02-25","conditions":"Insomnia","enrollment":673},{"nctId":"NCT05702398","phase":"EARLY_PHASE1","title":"Pilot Trial of Supplemental Vitamin A and Nicotinamide","status":"RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2023-04-01","conditions":"Skin Cancer, Kidney Transplant Recipients","enrollment":30},{"nctId":"NCT04944836","phase":"PHASE2","title":"Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-03-09","conditions":"Rotator Cuff Tears","enrollment":58},{"nctId":"NCT03844412","phase":"PHASE2","title":"Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments","status":"COMPLETED","sponsor":"Duke University","startDate":"2019-11-04","conditions":"Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome","enrollment":209},{"nctId":"NCT06164665","phase":"PHASE4","title":"Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude","status":"COMPLETED","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2023-03-01","conditions":"High Altitude","enrollment":9},{"nctId":"NCT06807866","phase":"PHASE4","title":"Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-03-01","conditions":"THA","enrollment":64},{"nctId":"NCT06093477","phase":"NA","title":"Studying Melatonin and Recovery in Teens","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-05-30","conditions":"Juvenile; Scoliosis, Scoliosis Idiopathic, Scoliosis; Adolescence","enrollment":45},{"nctId":"NCT02064673","phase":"PHASE3","title":"Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy","status":"RECRUITING","sponsor":"yair lotan","startDate":"2014-05","conditions":"Prostate Cancer","enrollment":608},{"nctId":"NCT06582888","phase":"EARLY_PHASE1","title":"Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-11-19","conditions":"Nicotine Addiction, Craving","enrollment":200},{"nctId":"NCT07061574","phase":"PHASE1, PHASE2","title":"A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-03-30","conditions":"Type 1 Diabetes, New Onset","enrollment":120},{"nctId":"NCT04791579","phase":"PHASE2","title":"Antibiotic Prophylaxis for Neurogenic Bladder Botox","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-02-01","conditions":"Neurogenic Bladder, Post-operative Urinary Tract Infections","enrollment":160},{"nctId":"NCT05886816","phase":"PHASE2","title":"Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-03-01","conditions":"SARS-CoV Infection, COVID-19","enrollment":112},{"nctId":"NCT04497168","phase":"PHASE2","title":"Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-04-01","conditions":"Parkinson Disease","enrollment":58},{"nctId":"NCT07466732","phase":"EARLY_PHASE1","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males","status":"ENROLLING_BY_INVITATION","sponsor":"Liverpool John Moores University","startDate":"2025-12-08","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT07373210","phase":"NA","title":"Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03","conditions":"Periacetabular Osteotomy, Opiates","enrollment":64},{"nctId":"NCT07469852","phase":"PHASE1, PHASE2","title":"Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males","status":"ACTIVE_NOT_RECRUITING","sponsor":"Liverpool John Moores University","startDate":"2026-01-12","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT07466628","phase":"PHASE4","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males","status":"COMPLETED","sponsor":"Liverpool John Moores University","startDate":"2024-11-15","conditions":"Caffine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT04916327","phase":"NA","title":"Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2021-08-23","conditions":"Peripheral Vascular Diseases","enrollment":720},{"nctId":"NCT06579209","phase":"NA","title":"NAD+ Oral Supplement Pilot Intervention in Adult Females","status":"COMPLETED","sponsor":"University of Rhode Island","startDate":"2024-12-01","conditions":"Cognitive Change, Inflammation, Neurodegenerative Diseases","enrollment":53},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":"Obesity, Metabolic Syndrome X","enrollment":128},{"nctId":"NCT04769206","phase":"PHASE1, PHASE2","title":"Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-12-20","conditions":"Endothelial Dysfunction","enrollment":46},{"nctId":"NCT05359653","phase":"PHASE1, PHASE2","title":"Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-08-01","conditions":"Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive","enrollment":74},{"nctId":"NCT06720909","phase":"NA","title":"Mindfulness And Placebo for Pain (MAPP) Study","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-01-27","conditions":"Chronic Pain","enrollment":45},{"nctId":"NCT05145452","phase":"NA","title":"n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy","status":"TERMINATED","sponsor":"University of Missouri-Columbia","startDate":"2021-01-14","conditions":"Diabetic Neuropathies","enrollment":31},{"nctId":"NCT06065670","phase":"PHASE1, PHASE2","title":"Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-09-15","conditions":"Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion","enrollment":44},{"nctId":"NCT05901571","phase":"NA","title":"Acupuncture and Escitalopram for Treating Major Depression Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 7th People's Hospital","startDate":"2026-11","conditions":"Depressive Disorder, Major","enrollment":216},{"nctId":"NCT05624528","phase":"PHASE2","title":"A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2023-06-22","conditions":"Obsessive-Compulsive Disorder, OCD","enrollment":49},{"nctId":"NCT04872660","phase":"PHASE4","title":"Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET","status":"RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2021-06-15","conditions":"Infertility, Female","enrollment":800},{"nctId":"NCT06408519","phase":"NA","title":"Open-Label Placebo for Non-Specific Pain in the ED","status":"COMPLETED","sponsor":"Bruno Minotti","startDate":"2024-05-23","conditions":"Pain, Acute","enrollment":57},{"nctId":"NCT06973109","phase":"PHASE2","title":"Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nitin Agarwal","startDate":"2026-03-20","conditions":"Osteoporosis, Post-menopausal","enrollment":36},{"nctId":"NCT05362292","phase":"PHASE4","title":"TReating Incontinence for Underlying Mental and Physical Health","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-10-04","conditions":"Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder","enrollment":270},{"nctId":"NCT03586284","phase":"PHASE2, PHASE3","title":"Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2020-03-15","conditions":"Cytomegalovirus Anterior Uveitis","enrollment":51},{"nctId":"NCT05061368","phase":"PHASE2","title":"Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-03-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":160},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT05350215","phase":"PHASE1, PHASE2","title":"Atomoxetine and DAW2022 on OSA Severity","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-06-01","conditions":"Obstructive Sleep Apnea","enrollment":18},{"nctId":"NCT06556277","phase":"NA","title":"Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake","status":"COMPLETED","sponsor":"Eleonora Seelig","startDate":"2024-09-01","conditions":"Glucocorticoids, Overweight and Obesity, Overeating","enrollment":23},{"nctId":"NCT05903859","phase":"PHASE3","title":"Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)","status":"RECRUITING","sponsor":"University of Miami","startDate":"2024-01-18","conditions":"Infertility, Male","enrollment":90},{"nctId":"NCT07439601","phase":"NA","title":"Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-02-28","conditions":"Focus on Omega 3 Index on Recovery","enrollment":46},{"nctId":"NCT07298993","phase":"PHASE4","title":"Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-02","conditions":"Heart Failure, HFpEF, HFpEF - Heart Failure With Preserved Ejection Fraction","enrollment":240},{"nctId":"NCT03598309","phase":"PHASE2","title":"Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-06-05","conditions":"Lung Diseases, Lung Cancer, Protection Against","enrollment":19},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT05729243","phase":"PHASE4","title":"Cytisine for Smoking Cessation","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-02-08","conditions":"Tobacco Use Disorder, Alcohol Use Disorder, Smoking Cessation","enrollment":20},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT03553875","phase":"PHASE3","title":"Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2018-11-13","conditions":"Autism, Autism Spectrum Disorder, Nonverbal Learning Disability","enrollment":25},{"nctId":"NCT07433452","phase":"PHASE1","title":"The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.","status":"NOT_YET_RECRUITING","sponsor":"Gabriella Gobbi","startDate":"2026-09-01","conditions":"Healthy Participants, Placebo - Control, Psilocybin","enrollment":50},{"nctId":"NCT06882772","phase":"PHASE1, PHASE2","title":"Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids","status":"NOT_YET_RECRUITING","sponsor":"University of Nebraska","startDate":"2026-03","conditions":"Congenital Heart Disease (CHD)","enrollment":105},{"nctId":"NCT05513560","phase":"PHASE2, PHASE3","title":"RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2023-05-31","conditions":"Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19","enrollment":460},{"nctId":"NCT07098975","phase":"PHASE2","title":"Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2026-01-14","conditions":"Preeclampsia (PE), Intrauterine Growth Restriction (IUGR), Placental Insufficiency","enrollment":154},{"nctId":"NCT05356013","phase":"PHASE2","title":"Caplyta in Borderline Personality Disorder","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2023-05-10","conditions":"Borderline Personality Disorder","enrollment":60},{"nctId":"NCT01410942","phase":"PHASE2","title":"Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-02-08","conditions":"Prostate Cancer","enrollment":175},{"nctId":"NCT07419594","phase":"NA","title":"Estradiol and Intrusive Memories","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2024-08-19","conditions":"PTSD, Intrusive Memories, Intrusion Symptom","enrollment":273},{"nctId":"NCT07281014","phase":"PHASE4","title":"Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-01-27","conditions":"Heart Failure","enrollment":20},{"nctId":"NCT05705427","phase":"PHASE4","title":"The COMBAT HBV Feasibility Trial","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-08-17","conditions":"Hepatitis B, Vertical Transmission of Infectious Disease","enrollment":317},{"nctId":"NCT07377136","phase":"NA","title":"Influence of the Urolithin A on the Population With BMI Higher Than 30 During Restricted Eating.","status":"ENROLLING_BY_INVITATION","sponsor":"Charles University, Czech Republic","startDate":"2025-10-08","conditions":"Obesity & Overweight","enrollment":100},{"nctId":"NCT06852365","phase":"PHASE2","title":"Combined Oral Contraceptive Pill and Resistance Starch","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-06-10","conditions":"Metabolic Syndrome, Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT03789760","phase":"PHASE3","title":"The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule","status":"COMPLETED","sponsor":"Shineway Pharmaceutical Co.,Ltd","startDate":"2019-04-10","conditions":"Vascular Dementia","enrollment":493},{"nctId":"NCT03229889","phase":"PHASE4","title":"Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2017-06-07","conditions":"Nephrolithiasis","enrollment":220},{"nctId":"NCT06957808","phase":"NA","title":"Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia","status":"RECRUITING","sponsor":"King's College London","startDate":"2025-01-10","conditions":"Schizophrenia Disorders","enrollment":30},{"nctId":"NCT07146451","phase":"","title":"6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-28","conditions":"Children Born to Mothers Enrolled in the TOCOPROM Trial","enrollment":480},{"nctId":"NCT07144826","phase":"EARLY_PHASE1","title":"Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-03-09","conditions":"Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma, Stage II Ovarian Cancer AJCC v8","enrollment":161},{"nctId":"NCT04276259","phase":"PHASE4","title":"Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses","status":"COMPLETED","sponsor":"Marta Peciña, MD PhD","startDate":"2020-10-19","conditions":"Major Depressive Disorder, Depression","enrollment":120},{"nctId":"NCT06573970","phase":"PHASE4","title":"Atomoxetine and Executive Function in PTSD","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Posttraumatic Stress Disorder With Attention Defic","enrollment":160},{"nctId":"NCT06438861","phase":"NA","title":"Role of Combination Therapy in Women With Refractory Overactive Bladder","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2025-01-01","conditions":"Overactive Bladder Syndrome","enrollment":""},{"nctId":"NCT06608433","phase":"NA","title":"Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-01-16","conditions":"Healthy Volunteer Study, HPA, Cortisol Deficiency","enrollment":22},{"nctId":"NCT07398508","phase":"PHASE1, PHASE2","title":"Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.","status":"RECRUITING","sponsor":"Stephen G. Kaler","startDate":"2026-06-01","conditions":"Menkes Disease","enrollment":6},{"nctId":"NCT04183205","phase":"PHASE4","title":"Predicting SSRI Efficacy in Veterans With PTSD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-09-11","conditions":"Posttraumatic Stress Disorder, Major Depressive Disorder","enrollment":26},{"nctId":"NCT06063200","phase":"EARLY_PHASE1","title":"Methylphenidate and Response to Alcohol Cues Pilot Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2024-03-20","conditions":"Alcohol Use Disorder, Attention Deficit Hyperactivity Disorder","enrollment":31},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT07323524","phase":"PHASE4","title":"Dapagliflozin in Active Lupus Nephritis","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-02-01","conditions":"Lupus Nephritis (LN)","enrollment":33},{"nctId":"NCT04850846","phase":"PHASE2","title":"Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-04-27","conditions":"Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma","enrollment":60},{"nctId":"NCT04383262","phase":"PHASE2","title":"Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction","status":"NOT_YET_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2026-04-01","conditions":"Laryngopharyngeal Reflux","enrollment":104},{"nctId":"NCT07396857","phase":"NA","title":"The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-11-01","conditions":"Cardiovascular","enrollment":40},{"nctId":"NCT07111988","phase":"PHASE2","title":"Valbenazine in Obsessive Compulsive Disorder","status":"NOT_YET_RECRUITING","sponsor":"University of Chicago","startDate":"2026-02","conditions":"Obsessive-Compulsive Disorder","enrollment":30},{"nctId":"NCT02655315","phase":"PHASE2","title":"Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2016-02-09","conditions":"Parkinson Disease","enrollment":372},{"nctId":"NCT04594746","phase":"PHASE4","title":"Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study","status":"TERMINATED","sponsor":"University of Calgary","startDate":"2022-02-03","conditions":"Atrial Fibrillation","enrollment":3},{"nctId":"NCT06281665","phase":"PHASE4","title":"Treatment With Aspirin After Preeclampsia: TAP Trial","status":"RECRUITING","sponsor":"Malamo Countouris","startDate":"2024-05-29","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":60},{"nctId":"NCT02595346","phase":"PHASE2","title":"Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2016-05-17","conditions":"Antiphospholipid Syndrome (APS)","enrollment":25},{"nctId":"NCT05421416","phase":"PHASE2","title":"Loratadine for the Prevention of G-CSF-related Bone Pain","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-11-28","conditions":"Stem Cell Transplant Complications","enrollment":78},{"nctId":"NCT05212298","phase":"NA","title":"Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus","status":"COMPLETED","sponsor":"Dalin Tzu Chi General Hospital","startDate":"2021-09-16","conditions":"Sleep Disturbances, Tinnitus","enrollment":108},{"nctId":"NCT04860141","phase":"PHASE4","title":"Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2021-06-16","conditions":"Dental Pain and Sensation Disorder, Pain, Postoperative","enrollment":98},{"nctId":"NCT04599504","phase":"PHASE2, PHASE3","title":"Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2022-01-02","conditions":"Loss-of-control Eating, Obesity/Overweight","enrollment":60},{"nctId":"NCT06377072","phase":"PHASE3","title":"Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Hutchison Pharmaceuticals Limited","startDate":"2024-05-11","conditions":"Cervical Spondylotic Myelopathy","enrollment":428},{"nctId":"NCT06222268","phase":"PHASE1","title":"Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery","status":"NOT_YET_RECRUITING","sponsor":"Wayne State University","startDate":"2026-03","conditions":"PTSD, Post Traumatic Stress Disorder","enrollment":280},{"nctId":"NCT07223580","phase":"PHASE4","title":"A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-23","conditions":"Ureteroscopy, Post Operative Pain","enrollment":90},{"nctId":"NCT04666636","phase":"PHASE2","title":"Mechanisms for Activation of Beige Adipose Tissue in Humans","status":"RECRUITING","sponsor":"Philip Kern","startDate":"2020-12-07","conditions":"PreDiabetes","enrollment":65},{"nctId":"NCT05147090","phase":"PHASE4","title":"Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2022-01-02","conditions":"Chronic Hepatitis b, NAFLD, Cirrhosis","enrollment":106},{"nctId":"NCT03944629","phase":"","title":"Efficacy of Arnica Montana in Reducing Postoperative Edema and Pain","status":"COMPLETED","sponsor":"Tufts University","startDate":"2018-01-26","conditions":"Arnica, Third Molar Extraction","enrollment":53}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":224,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Estrace® Tablets","Placebo","lactose","placebo"],"phase":"marketed","status":"active","brandName":"Placebo Pills","genericName":"Placebo Pills","companyName":"NYU Langone Health","companyId":"nyu-langone-health","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":1},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T05:43:22.112376+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}